Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Harvard Business School
AstraZeneca
Argus Health
Cerilliant
Chinese Patent Office
Citi
Boehringer Ingelheim
Fish and Richardson

Generated: May 21, 2018

DrugPatentWatch Database Preview

DEXAMPEX Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Dexampex, and what generic alternatives are available?

Dexampex is a drug marketed by Teva and is included in two NDAs.

The generic ingredient in DEXAMPEX is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
Summary for DEXAMPEX
US Patents:0
Applicants:1
NDAs:2
Formulation / Manufacturing:see details
DailyMed Link:DEXAMPEX at DailyMed
Drug patent expirations by year for DEXAMPEX
Medical Subject Heading (MeSH) Categories for DEXAMPEX

US Patents and Regulatory Information for DEXAMPEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva DEXAMPEX dextroamphetamine sulfate CAPSULE;ORAL 085355-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva DEXAMPEX dextroamphetamine sulfate TABLET;ORAL 083735-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva DEXAMPEX dextroamphetamine sulfate TABLET;ORAL 083735-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Deloitte
QuintilesIMS
Moodys
Teva
Chinese Patent Office
Accenture
McKesson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.